Memorial Sloan Kettering’s team for treating benign blood disorders includes two board-certified hematologists, one clinical nurse, and four nurse practitioners whose sole focus is to diagnose and address these conditions before they become life threatening. We collaborate with medical oncologists, radiation oncologists, surgeons, and other staff at Memorial Sloan Kettering to identify patients who may be at risk of blood-related complications and to develop a coordinated treatment plan.
When treatment for a blood clot, bleeding disorder, or anemia is necessary, our team works aggressively to reverse the problem so that you can safely return to your cancer treatment. Our specially trained nurse practitioners and hematologists continue to monitor your care throughout the course of your cancer treatment.
Our team is conducting scientific research to improve strategies for preventing blood clots, thrombocytopenia, and other noncancerous blood disorders that are caused by cancer or chemotherapy. Our hematologists also have expertise caring for patients who have blood disorders that are not caused by cancer or cancer treatment.
Select from the list below to learn more about our benign blood disorder specialists, their education, training, board certifications, current publications, and specific areas of clinical expertise.